Jefferson E. Davis's most recent trade in Acer Therapeutics Inc was a trade of 30,000 Employee Stock Option (right to buy) done . Disclosure was reported to the exchange on March 14, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acer Therapeutics Inc | Jefferson E. Davis | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2023 | 30,000 | 30,000 | - | - | Employee Stock Option (right to buy) | |
| Acer Therapeutics Inc | Jefferson E. Davis | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2022 | 25,000 | 25,000 | - | - | Employee Stock Option (right to buy) | |
| Acer Therapeutics Inc | Jefferson E. Davis | Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2021 | 100,000 | 100,000 | - | - | Employee Stock Option (right to buy) |